Qiagen NV (NYSE:QGEN) price on Thursday, July 03, fall -0.62% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $48.34.
A look at the stock’s price movement, the close in the last trading session was $48.64, moving within a range at $47.97 and $48.63. The beta value (5-Year monthly) was 0.673 while the PE ratio in trailing twelve months stood at 115.81. Turning to its 52-week performance, $48.82 and $37.63 were the 52-week high and 52-week low respectively. Overall, QGEN moved 6.76% over the past month.
Qiagen NV’s market cap currently stands at around $10.47 billion, with investors looking forward to this quarter’s earnings report slated for on 2025-May-07. The company has a Forward Dividend ratio of 0.25, with its dividend yield at 0.52%. As such, investors might be keen on an upside in the stock’s price ahead of the scheduled earnings report.
Turning to the stock’s technical picture we see that short term indicators suggest on average that QGEN is a 100% Buy. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
5 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 4 recommend QGEN as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
The technical evaluation for the stock shows the PEG ratio is 15.84, with QGEN’s current price about 2.59% and 8.28% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 68.89, while 7-day volatility ratio is 1.71% and 1.52% in the 30-day chart. Further, Qiagen NV (QGEN) has a beta value of 0.65. Analysts have given the company’s stock an average 52-week price target of $50.246337372, forecast between a low of $46 and high of $58. Looking at the price targets, the low is 4.84% off current price level while to achieve the yearly target high, price needs to move -19.98%. Nonetheless, investors will most likely welcome a -3.94% jump to $50.246337372 which is the analysts’ median price.
If we refocus on Qiagen NV (NYSE:QGEN), historical trading data shows that trading volumes averaged 1.37 over the past 10 days and 1.49 million over the past 3 months. The company’s latest data on shares outstanding shows there are 216.56 million shares.
The 0.79% of Qiagen NV’s shares are in the hands of company insiders while institutional holders own 71.57% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 5.65 million on 2025-06-13, giving us a short ratio of 3.83. The data shows that as of 2025-06-13 short interest in Qiagen NV (QGEN) stood at 386.99999999999994 of shares outstanding, with shares short falling to 6.06 million registered in 2025-05-15. Current price change has pushed the stock 20.18% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the QGEN stock continues to rise going into the next quarter.
